
Eocene Ltd. (EOCN)
Last updated: 2026-10-24 18:02:00. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Summary
Eocene Ltd. (EOCN) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $3.03, with a market capitalization of $3.29M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $2.33 to $4.88. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$3.29M | |
$3.03 | |
$4.88 | |
$2.33 | |
$3.08 | |
2.00 | |
15.20K | |
-- | |
$4.88 | |
$2.33 | |
-- | |
-- |
Eocene Ltd. (EOCN) Latest Closing Stock Price
Eocene Ltd. (EOCN) last closed at $3.08 as of 2026-10-23 22:37:00, unchanged from the previous close of $3.08.
During the latest regular trading session, EOCN traded between $2.33 and $4.88, with a volume of 2.00 shares. The closing price was near the lower end and near the lower end of its 52-week range.
Eocene Ltd. (EOCN) 7-Day Stock Price Change
Over the past seven days, Eocene Ltd. (EOCN) moved from $3.05 to $3.03, representing a decline of 0.66% ($0.02).
The stock traded between $2.33 and $3.27 during the period. The latest price is near the upper end of the 7-day range, indicating moderate downward.
The average daily volume was 7.20 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
EOCN 52-Week Price Position
Position in Range: 27.5%
EOCN is currently trading at $3.03, placing it 27.5% of the way from its 52-week low of $2.33 to its 52-week high of $4.88. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Eocene Ltd. (EOCN)?
Eocene Ltd is a GI-focused medtech and biopharmaceutical company focused on advancing solutions across gastrointestinal disease management, GI oncology and related therapeutic areas. Its wholly owned subsidiary develops medical devices for postoperative colorectal care, including CG-100, an intraluminal bypass device intended to protect colorectal anastomoses and reduce the need for diverting stomas. The company's therapeutic portfolio includes Aramchol, a first-in-class synthetic fatty acid-bile acid conjugate molecule being evaluated in liver disease and oncology indications, including gastrointestinal cancers.
Eocene Ltd. Information
| Employees | 6 |
| Exchange | NASDAQ |
| Company Website |
How to Buy Eocene Ltd. (EOCN) Stock on MEXC
Eligible investors can buy real shares of Eocene Ltd. (EOCN) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Eocene Ltd. (EOCN) stock price today?
2.Is EOCN stock going up or down today?
3.What is EOCN pre-market price?
4.What is EOCN after-hours price?
5.Is EOCN stock trading now?
6.Where does EOCN sit relative to its 52-week high and low?
7.What sector is Eocene Ltd. in?
8.What is Eocene Ltd.'s market capitalization and where is it listed?
9.How is EOCN valued in terms of P/E ratio and EPS?
10.Does Eocene Ltd. pay a dividend?
Explore More US Stocks
Search Stocks
EOCN Stock Calculator
Estimate the value between EOCN shares and USD.
EOCN Shares to USD
1.00 EOCN shares = 3.03 USD
Calculations are estimates based on the latest available price and are for reference only.

